Navigation

Search the NICE 'do not do' recommendations database

You can search the NICE 'do not do' recommendations database by:

  • typing in a specific term in the 'do not do' recommendations box
  • selecting an appropriate topic
  • selecting the type of source guidance.

To see the full list of all NICE 'do not do' recommendations leave all the fields blank and click the 'Search' button.

Hypertension in pregnancy

Results 1-10 of 28

Guidance ID NICE 'do not do' recommendation Interventions
CG107 Do not use nitric oxide donors to prevent hypertensive disorders during pregnancy. nitric oxide donors
CG107 Do not recommend magnesium solely with the aim of preventing hypertensive disorders during pregnancy. magnesium
CG107 Do not offer pregnant women with uncomplicated chronic hypertension treatment to lower diastolic blood pressure below 80 mmHg. lowering diastolic blood pressure
CG107 Do not offer birth to women with chronic hypertension whose blood pressure is lower than 160/110 mmHg, with or without antihypertensive treatment, before 37 weeks. birth before 37 weeks
CG107 Do not offer bed rest in hospital as a treatment for gestational hypertension. hospital bed rest
CG107 Do not offer birth before 37 weeks to women with gestational hypertension whose blood pressure is lower than 160/110 mmHg, with or without antihypertensive treatment. birth before 37 weeks
CG107 In women with pre-eclampsia who have given birth and have stepped down from critical care level 2, do not measure fluid balance if creatinine is within the normal range. fluid balance meaurement
CG107 In women with chronic hypertension, carry out ultrasound fetal growth and amniotic fluid volume assessment and umbilical artery doppler velocimetry between 28 and 30 weeks and between 32 and 34 weeks. If results are normal, do not repeat at more than 34 weeks, unless otherwise clinically indicated. ultrasound fetal growth; amniotic fluid volume assessment; umbilical artery doppler velocimetry
CG107 In women with mild or moderate gestational hypertension, carry out ultrasound fetal growth and amniotic fluid volume assessment and umbilical artery doppler velocimetry if diagnosis is confirmed at less than 34 weeks. If results are normal, do not repeat at more than 34 weeks, unless otherwise clinically indicated. ultrasound fetal growth; amniotic fluid volume assessment; umbilical artery doppler velocimetry
CG107 If the results of all fetal monitoring are normal in women with severe gestational hypertension or pre-eclampsia, do not routinely repeat cardiotocography more than weekly. cardiotocography

Back to ´do not do´ recommendations home

This page was last updated: 28 March 2014

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.